Column Capital Advisors, LLC Astrazeneca PLC Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
A detailed history of Column Capital Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Column Capital Advisors, LLC holds 286 shares of AZN stock, worth $19,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286
Previous 286
-0.0%
Holding current value
$19,722
Previous $20,000
5.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.89 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...